|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| A61K 49/00 | (2006.01) | ||
| A61K 51/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1704864 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06012171.2 |
| Date of filing the European patent application | 2000-06-07 | |
| (97) | Date of publication of the European application | 2006-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2012-05-23 |
| (46) | Date of publication of the claims translation | 2012-08-27 |
| (30) | Number | Date | Country code |
| 19926154 | 1999-06-09 | DE |
| (72) |
Kratz, Felix, DE
|
| (73) |
KTB Tumorforschungs GmbH,
Breisacher Strasse 17, 79106 Freiburg,
DE
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Injekcinis farmacinis preparatas, susidedantis iš intarpu surištų citostatinio agento ir maleinimido |
| Injectable pharmaceutical preparation consisting of a cytostatic agent and a maleinimide linked by a spacer. |
| Payment date | Validity (years) | Amount | |
| 2017-09-20 | 18 | 520.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-06-07 |